Literature DB >> 19012062

A case of bilateral cochlear implantation in single-sided untreated acoustic neurinoma.

Silke Helbig1, Tobias Rader, Andreas Bahmer, Uwe Baumann.   

Abstract

Acoustic neurinoma affects the acousticofacial nerve and therefore in many cases is a contraindication for cochlear implantation and an indication for brainstem implant. Nevertheless benefit in these patients has been shown after tumour removal and cochlear implantation. The first case of bilateral cochlear implantation in a patient with single-sided untreated acoustic neurinoma is described here. In a 49-year-old woman with progressive hearing loss during the last 12 years we preoperatively diagnosed an acoustic neurinoma of the left side. After cochlear implantation of the right side she was sequentially implanted on the affected side as well. Before surgery radiological control of the tumour for signs of growth was performed and the patient was thoroughly informed of the situation and possible therapies and dangers. Speech discrimination scores obtained in the second implanted ear came up to the performance of the first implant after 6 months.

Entities:  

Mesh:

Year:  2009        PMID: 19012062     DOI: 10.1080/00016480802527545

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Cochlear Implantation in Sporadic Vestibular Schwannoma: A Systematic Literature Review.

Authors:  Matthew Robert Bartindale; Kent Sean Tadokoro; Matthew Lowell Kircher
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-08

2.  Imaging in cochlear implant patients.

Authors:  Antje Aschendorff
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

3.  Magnetic Resonance Imaging Artifacts and Cochlear Implant Positioning at 1.5 T In Vivo.

Authors:  Dirk Schröder; Gloria Grupe; Grit Rademacher; Sven Mutze; Arneborg Ernst; Rainer Seidl; Philipp Mittmann
Journal:  Biomed Res Int       Date:  2018-11-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.